Fig. 9From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)P-bi-TAT levels in the brain of rats (n = 4) at low (1 mg/kg), medium (3 mg/kg), and high (10 mg/kg) doses. Error bars represent standard errors of the meanBack to article page